DVLIX
Price
$29.96
Change
-$0.59 (-1.93%)
Updated
May 21 closing price
Net Assets
381.85M
VIMSX
Price
$73.08
Change
-$1.55 (-2.08%)
Updated
May 21 closing price
Net Assets
175.12B
Interact to see
Advertisement

DVLIX vs VIMSX

Header iconDVLIX vs VIMSX Comparison
Open Charts DVLIX vs VIMSXBanner chart's image
BNY Mellon Opportunistic Midcap Value I
Price$29.96
Change-$0.59 (-1.93%)
VolumeN/A
Net Assets381.85M
Vanguard Mid Cap Index Investor
Price$73.08
Change-$1.55 (-2.08%)
VolumeN/A
Net Assets175.12B
DVLIX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DVLIX vs. VIMSX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVLIX is a Buy and VIMSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 175B vs. DVLIX (382M). VIMSX pays higher dividends than DVLIX: VIMSX (1.48) vs DVLIX (0.60). DVLIX was incepted earlier than VIMSX: DVLIX (17 years) vs VIMSX (27 years). DVLIX (0.97) is less costly to investors than VIMSX (0.17). DVLIX is a more actively managed with annual turnover of: 58.67 vs. VIMSX (16.00). DVLIX has a lower initial minimum investment than VIMSX: DVLIX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 10.18 vs. DVLIX (-4.87). VIMSX return over 5 years is better than : 78.35 vs. DVLIX (34.12).
DVLIXVIMSXDVLIX / VIMSX
Total Expense Ratio0.970.17571%
Annual Report Gross Expense Ratio0.970.17571%
Fund Existence17 years27 years-
Gain YTD1.5623.61243%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets382M175B0%
Annual Yield % from dividends0.601.4840%
Returns for 1 year-4.8710.18-48%
Returns for 3 years3.2532.4510%
Returns for 5 years34.1278.3544%
Returns for 10 years-24.46112.78-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGEMX23.41N/A
N/A
Morgan Stanley Inst Emerging Mkts I
GTMUX23.19N/A
N/A
Goldman Sachs Small/Mid Cap Growth R6
LAFPX19.18N/A
N/A
Lord Abbett Affiliated P
GPEIX12.23N/A
N/A
Grandeur Peak Emerg Mkts Opps Instl
HCPSX74.24N/A
N/A
ProFunds UltraSector Health Care Svc